Prøv GOLD - Gratis
Shot at Weight Loss
Business Today India
|April 13, 2025
Eli Lilly has launched weight-loss drug Mounjaro in India, priced at ₹3,500 per injection for a 2.5mg dose. Will high costs be a barrier to the reach?
WITH DIABETES AND obesity cases surging in India, pharmaceutical giant Eli Lilly and Company (India) has launched Mounjaro (tirzepatide), a once-weekly injectable drug for chronic weight management and type 2 diabetes.
Approved by the Central Drugs Standard Control Organization (CDSCO), Mounjaro is the first dual-target therapy that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, helping regulate blood sugar levels while promoting weight loss. The 2.5 mg dose is priced at ₹3,500 per injection, with a monthly cost of ₹14,000, while the 5 mg dose is ₹4,375 per injection.
Denne historie er fra April 13, 2025-udgaven af Business Today India.
Abonner på Magzter GOLD for at få adgang til tusindvis af udvalgte premiumhistorier og 10.000+ magasiner og aviser.
Allerede abonnent? Log ind
FLERE HISTORIER FRA Business Today India
Business Today India
“AI NOT A THREAT, BUT A FORCE MULTIPLIER”
Global and domestic IT majors have shed employees due to the adoption of AI.
1 mins
July 05, 2026
Business Today India
“SOLUTION TO THE CRISIS IS REFORMS TO PROMOTE EXPORTS”
Montek Singh Ahluwalia, former Deputy Chairman of the Planning Commission, on impact of the West Asia conflict on the economy, reliance on imports, and what can be done to push growth
6 mins
July 05, 2026
Business Today India
Ready for Take-Off
SLEEK, SMART AND DESIGNED FOR THE DISCERNING TRAVELLER, THESE NEW LUXURY CABIN CASES ARE REDEFINING WHAT IT MEANS TO TRAVEL LIGHT
2 mins
July 05, 2026
Business Today India
Why Ecosystems are Key to Manufacturing Competitiveness
India opened its economy but failed to build industrial depth
4 mins
July 05, 2026
Business Today India
UNHEALTHY DEPENDENCE
INDIA EXPORTS PHARMACEUTICALS WORTH $30.5 BILLION ANNUALLY BUT REMAINS HEAVILY DEPENDENT ON CHINA FOR RAW MATERIALS. THIS IS EMERGING AS ONE OF THE BIGGEST CHALLENGES TO THE COUNTRY'S HEALTHCARE AND MANUFACTURING AMBITIONS
4 mins
July 05, 2026
Business Today India
“FOSSIL FUELS SHOULD BE PHASED-DOWN RATHER THAN PHASED-OUT”
Bhupender Yadav on India’s clean-energy transition, climate finance, pollution control and balancing energy security with national sustainability goals
5 mins
July 05, 2026
Business Today India
FOREIGN WINGS
THE WORLD'S THIRD-LARGEST AVIATION MARKET DOES NOT MANUFACTURE A SINGLE COMMERCIAL AIRCRAFT, AN ENGINE, A SIMULATOR, OR THE SOFTWARE THAT BOOKS ITS TICKETS. RECENT DEVELOPMENTS SUGGEST THAT EFFORTS ARE BEING MADE TO OVERTURN THAT PERCEPTION
8 mins
July 05, 2026
Business Today India
FOOD SECURITY'S FOREIGN CRUTCH
WITH APPROPRIATE POLICY RESPONSES, IMPORT DEPENDENCE IN EDIBLE OILS, PULSES AND FERTILISERS CAN BE REVERSED
5 mins
July 05, 2026
Business Today India
AI'S DOLLAR DRAIN
INDIA’S OVERDEPENDENCE ON FOREIGN ARTIFICIAL INTELLIGENCE MODELS RISKS A LARGE FOREX OUTFLOW, ESPECIALLY AS MANY OF THEM ARE CURRENTLY FREE FOR END USERS. CAN LOCAL ALTERNATIVES CATCH UP TO ARREST DOLLAR FLIGHT IN THIS FOUNDATIONAL TECH?
5 mins
July 05, 2026
Business Today India
BORROWED STACK
BENEATH INDIA'S TECHNOLOGY SUCCESS STORY LIES AN UNCOMFORTABLE REALITY. THE COUNTRY STILL RUNS MUCH OF ITS DIGITAL FUTURE ON A BORROWED STACK. CAN IT CONTROL TECHNOLOGIES THAT UNDERPIN THE DIGITAL ECONOMY?
4 mins
July 05, 2026
Listen
Translate
Change font size